348 related articles for article (PubMed ID: 28555350)
1. Membranous nephropathy-one morphologic pattern with different diseases.
Hoxha E; von Haxthausen F; Wiech T; Stahl RAK
Pflugers Arch; 2017 Aug; 469(7-8):989-996. PubMed ID: 28555350
[TBL] [Abstract][Full Text] [Related]
2. Antigen-Specific IgG Subclasses in Primary and Malignancy-Associated Membranous Nephropathy.
von Haxthausen F; Reinhard L; Pinnschmidt HO; Rink M; Soave A; Hoxha E; Stahl RAK
Front Immunol; 2018; 9():3035. PubMed ID: 30619370
[TBL] [Abstract][Full Text] [Related]
3. Membranous Nephropathy and Anti-Podocytes Antibodies: Implications for the Diagnostic Workup and Disease Management.
Pozdzik A; Brochériou I; David C; Touzani F; Goujon JM; Wissing KM
Biomed Res Int; 2018; 2018():6281054. PubMed ID: 29511687
[TBL] [Abstract][Full Text] [Related]
4. Thrombospondin type-1 domain-containing 7A-associated membranous nephropathy after resection of rectal cancer: a case report.
Taguchi S; Koshikawa Y; Ohyama S; Miyachi H; Ozawa H; Asada H
BMC Nephrol; 2019 Feb; 20(1):43. PubMed ID: 30727973
[TBL] [Abstract][Full Text] [Related]
5. A Novel Insight into the Role of PLA2R and THSD7A in Membranous Nephropathy.
Zhang P; Huang W; Zheng Q; Tang J; Dong Z; Jiang Y; Liu Y; Liu W
J Immunol Res; 2021; 2021():8163298. PubMed ID: 34337081
[TBL] [Abstract][Full Text] [Related]
6. Immunological Pathogenesis of Membranous Nephropathy: Focus on PLA2R1 and Its Role.
Liu W; Gao C; Dai H; Zheng Y; Dong Z; Gao Y; Liu F; Zhang Z; Liu Z; Liu W; Liu B; Liu Q; Shi J
Front Immunol; 2019; 10():1809. PubMed ID: 31447839
[TBL] [Abstract][Full Text] [Related]
7. [Update membranous nephropathy].
Hoxha E; Huber TB
Dtsch Med Wochenschr; 2020 Oct; 145(20):1481-1485. PubMed ID: 33022730
[TBL] [Abstract][Full Text] [Related]
8. [Membranous glomerulonephritis : An example of individualized medicine in nephrology].
Stahl RAK; Hoxha E
Internist (Berl); 2019 May; 60(5):440-449. PubMed ID: 30859275
[TBL] [Abstract][Full Text] [Related]
9. Autoantibodies against thrombospondin type 1 domain-containing 7A induce membranous nephropathy.
Tomas NM; Hoxha E; Reinicke AT; Fester L; Helmchen U; Gerth J; Bachmann F; Budde K; Koch-Nolte F; Zahner G; Rune G; Lambeau G; Meyer-Schwesinger C; Stahl RA
J Clin Invest; 2016 Jul; 126(7):2519-32. PubMed ID: 27214550
[TBL] [Abstract][Full Text] [Related]
10. Thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy.
Tomas NM; Beck LH; Meyer-Schwesinger C; Seitz-Polski B; Ma H; Zahner G; Dolla G; Hoxha E; Helmchen U; Dabert-Gay AS; Debayle D; Merchant M; Klein J; Salant DJ; Stahl RAK; Lambeau G
N Engl J Med; 2014 Dec; 371(24):2277-2287. PubMed ID: 25394321
[TBL] [Abstract][Full Text] [Related]
11. Molecular classification of membranous nephropathy.
Pozdzik A; Touzani F; Brochériou I; Corazza F
Curr Opin Nephrol Hypertens; 2019 Jul; 28(4):336-344. PubMed ID: 31045661
[TBL] [Abstract][Full Text] [Related]
12. Unmet challenges in membranous nephropathy.
Salant DJ
Curr Opin Nephrol Hypertens; 2019 Jan; 28(1):70-76. PubMed ID: 30451735
[TBL] [Abstract][Full Text] [Related]
13. Recurrent membranous nephropathy with a possible alteration in the etiology: a case report.
Matsumoto A; Matsui I; Mano K; Mizuno H; Katsuma Y; Yasuda S; Shimada K; Inoue K; Oki T; Hanai T; Kojima K; Kaneko T; Isaka Y
BMC Nephrol; 2021 Jul; 22(1):253. PubMed ID: 34229600
[TBL] [Abstract][Full Text] [Related]
14. Novel ELISA for thrombospondin type 1 domain-containing 7A autoantibodies in membranous nephropathy.
Zaghrini C; Seitz-Polski B; Justino J; Dolla G; Payré C; Jourde-Chiche N; Van de Logt AE; Booth C; Rigby E; Lonnbro-Widgren J; Nystrom J; Mariat C; Cui Z; Wetzels JFM; Ghiggeri G; Beck LH; Ronco P; Debiec H; Lambeau G
Kidney Int; 2019 Mar; 95(3):666-679. PubMed ID: 30784662
[TBL] [Abstract][Full Text] [Related]
15. PLA2R and THSD7A: Disparate Paths to the Same Disease?
Beck LH
J Am Soc Nephrol; 2017 Sep; 28(9):2579-2589. PubMed ID: 28674044
[TBL] [Abstract][Full Text] [Related]
16. An Indirect Immunofluorescence Method Facilitates Detection of Thrombospondin Type 1 Domain-Containing 7A-Specific Antibodies in Membranous Nephropathy.
Hoxha E; Beck LH; Wiech T; Tomas NM; Probst C; Mindorf S; Meyer-Schwesinger C; Zahner G; Stahl PR; Schöpper R; Panzer U; Harendza S; Helmchen U; Salant DJ; Stahl RA
J Am Soc Nephrol; 2017 Feb; 28(2):520-531. PubMed ID: 27436855
[TBL] [Abstract][Full Text] [Related]
17. Is primary membranous nephropathy a complement mediated disease?
Reinhard L; Stahl RAK; Hoxha E
Mol Immunol; 2020 Dec; 128():195-204. PubMed ID: 33142137
[TBL] [Abstract][Full Text] [Related]
18. Multi-Autoantibody Signature and Clinical Outcome in Membranous Nephropathy.
Ghiggeri GM; Seitz-Polski B; Justino J; Zaghrini C; Payré C; Brglez V; Dolla G; Sinico A; Scolari F; Vaglio A; Prunotto M; Candiano G; Radice A; Bruschi M; Lambeau G;
Clin J Am Soc Nephrol; 2020 Dec; 15(12):1762-1776. PubMed ID: 33257410
[TBL] [Abstract][Full Text] [Related]
19. Characterization of autoantibodies in primary membranous nephropathy and their clinical significance.
Stahl RA; Reinhard L; Hoxha E
Expert Rev Clin Immunol; 2019 Feb; 15(2):165-175. PubMed ID: 30433832
[No Abstract] [Full Text] [Related]
20. Podocyte Antigen Staining to Identify Distinct Phenotypes and Outcomes in Membranous Nephropathy: A Retrospective Multicenter Cohort Study.
Hanset N; Aydin S; Demoulin N; Cosyns JP; Castanares-Zapatero D; Crott R; Cambier JF; Pochet JM; Gillerot G; Reginster F; Houssiau F; Debiec H; Ronco P; Jadoul M; Morelle J;
Am J Kidney Dis; 2020 Nov; 76(5):624-635. PubMed ID: 32668319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
